$94.77 -0.21 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Nov. 24, 2014 | 04:00 PM

Partner Headlines

  1. Can Partnering To Fight Hepatitis C Pay At Entanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  2. Can Partnering To Fight Hepatitis C Pay At Enanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  3. Will IPOs WhiteWave, Enanta Surpass Buy Points?

    IBD | Nov. 17, 2014 | 18:27PM EST
  4. Novartis Int'l Reports Nine New Analyses Show Co.'s LCZ696 Could Avert Course of Heart Failure for Patients

    Benzinga | Nov. 17, 2014 | 16:47PM EST
  5. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  6. Kahn Brothers' Third Quarter Numbers

    GuruFocus | Nov. 7, 2014 | 17:43PM EST
  7. Veeva Systems Flies High On Cloud For Life Sciences

    IBD | Oct. 30, 2014 | 17:31PM EST
  8. Novartis

    IBD | Oct. 28, 2014 | 18:46PM EST
  9. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  10. Novartis Posts Higher Q3 Profit

    Benzinga | Oct. 28, 2014 | 06:17AM EST
  11. Drug ETFs Attractive Buys On Pullback

    Benzinga | Oct. 22, 2014 | 17:10PM EST
  12. Can Valeant's Strong Q3 Entice Allergan?

    IBD | Oct. 20, 2014 | 18:47PM EST
  13. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  14. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Oct. 10, 2014 | 07:20AM EST
  15. New MS Drugs Offer Promise

    IBD | Sep. 26, 2014 | 18:56PM EST
  16. Multiple Sclerosis Drugs Could Transform Market Again

    IBD | Sep. 26, 2014 | 18:07PM EST
  17. International Securities For A Diversified Income Portfolio

    GuruFocus | Sep. 23, 2014 | 13:36PM EST
  18. Could European Funds Offer An Opportunity Now?

    Benzinga | Sep. 23, 2014 | 10:04AM EST
  19. IPO Stock Watch: Biotech ProQR Rises In IPO Debut

    IBD | Sep. 18, 2014 | 12:54PM EST
  20. 3 Companies Investing In Stem Cell Research

    Benzinga | Sep. 14, 2014 | 16:34PM EST
  21. Good news for Receptos drug

    IBD | Sep. 10, 2014 | 18:53PM EST
  22. ReceptosMS Drug Yields More Good Data; Stock Jumps

    IBD | Sep. 10, 2014 | 11:58AM EST
  23. ECB Decision Boosts ETFs

    Benzinga | Sep. 4, 2014 | 16:02PM EST
  24. Novartis Drug Is Heartening

    IBD | Sep. 2, 2014 | 18:39PM EST
  25. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD | Sep. 2, 2014 | 18:04PM EST
  26. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD | Sep. 2, 2014 | 11:19AM EST
  27. Benzinga's Volume Movers

    Benzinga | Sep. 2, 2014 | 10:25AM EST
  28. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  29. Novartis: Ten Years of Solid ROE

    GuruFocus | Jul. 31, 2014 | 19:06PM EST
  30. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD | Jul. 23, 2014 | 18:17PM EST
  31. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD | Jul. 23, 2014 | 11:56AM EST
  32. 5 New Medical Technologies For Diabetics

    Benzinga | Jul. 18, 2014 | 13:10PM EST
  33. Novartis Joins Google To Develop Contacts For Diabetics

    Benzinga | Jul. 18, 2014 | 09:59AM EST
  34. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West At An All Time High

    Benzinga | Jul. 18, 2014 | 07:16AM EST
  35. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga | Jul. 17, 2014 | 16:50PM EST
  36. Earnings Scheduled For July 17, 2014

    Benzinga | Jul. 17, 2014 | 05:08AM EST
  37. Google's X division

    IBD | Jul. 15, 2014 | 19:15PM EST
  38. Benzinga Weekly Preview: Earnings Season Kicks Into High Gear

    Benzinga | Jul. 11, 2014 | 16:44PM EST
  39. NOVARTIS

    IBD | Jul. 9, 2014 | 18:48PM EST
  40. Novartis Announces Beginning of Shipment of Seasonal Influenza Vaccines to US Market for '14-'15 Season

    Benzinga | Jul. 2, 2014 | 16:33PM EST
  41. US Stock Futures Edge Higher Ahead Of Consumer Price Index

    Benzinga | Jun. 17, 2014 | 07:30AM EST
  42. IPO Stock Watch: Receptos Soars On MS Drug Results

    IBD | Jun. 10, 2014 | 16:24PM EST
  43. Joseph Papa, A Generic CEO With Brand-Name Action

    IBD | Jun. 6, 2014 | 13:34PM EST
  44. ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects

    Benzinga | Jun. 4, 2014 | 10:11AM EST
  45. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus | Jun. 2, 2014 | 18:35PM EST
  46. Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks

    GuruFocus | May. 29, 2014 | 19:32PM EST
  47. Two New WisdomTree International ETFs (IHDG, EUDG, BHP, NVS)

    Benzinga | May. 14, 2014 | 07:24AM EST
  48. Cross-Border Megamergers Drive Global Takeover Boom

    IBD | May. 12, 2014 | 17:01PM EST
  49. Can Pfizer Make Up Its Loss?

    GuruFocus | May. 9, 2014 | 19:24PM EST
  50. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD | May. 6, 2014 | 18:16PM EST
Trading Center